TOP > 外国特許検索 > Organic-inorganic hybrid particles containing contrast agent

Organic-inorganic hybrid particles containing contrast agent

外国特許コード F110005226
整理番号 A252-38WO
掲載日 2011年8月26日
出願国 アメリカ合衆国
出願番号 73480807
公報番号 20100278737
公報番号 8871180
出願日 平成19年9月4日(2007.9.4)
公報発行日 平成22年11月4日(2010.11.4)
公報発行日 平成26年10月28日(2014.10.28)
国際出願番号 JP2007067556
国際公開番号 WO2008068939
国際出願日 平成19年9月4日(2007.9.4)
国際公開日 平成20年6月12日(2008.6.12)
優先権データ
  • 特願2006-330436 (2006.12.7) JP
  • 2007WO-JP67556 (2007.9.4) WO
発明の名称 (英語) Organic-inorganic hybrid particles containing contrast agent
発明の概要(英語) (US8871180)
This invention provides organic-inorganic hybrid particles containing as the essential components a block copolymer comprising an uncharged hydrophilic polymer chain segment and a polymer chain segment containing a repeated structural unit having a carboxylate ion group at its side chain; calcium ion (Ca2+), phosphate ion (PO43-) or carbonate ion (CO32-), or a mixture of these anions; and a contrast agent.
The particles provide, in particular, carriers for stably delivering an MRI contrast agent to a target site.
特許請求の範囲(英語) [claim1]
1. An organic-inorganic hybrid particle comprising as essential components, a block copolymer comprising a structure represented by a formula (I):
poly(hph)-block-poly(carbo) (I)
wherein poly(hph) represents a hydrophilic polymer chain segment derived from a water-soluble polymer selected from the group consisting of poly(ethylene glycol), poly(2-methyl-2-oxazoline), poly(2-ethyl-2-oxazoline), poly(2-isopropyl-2-oxazoline), poly(acrylamide), poly(methacrylamide), poly(vinyl alcohol), poly(hydroxyethyl acrylate) and poly(hydroxyethyl methacrylate);
poly(carbo) represents a polymer chain segment containing a recurring structural unit having a carboxylate ion group at its side chain, wherein the polymer chain segment is derived from the group consisting of poly(asparatic acid), poly(glutamic acid), poly(acrylic acid), poly(methacrylic acid), poly(malic acid) and random or block copolymers produced from at least two monomers for making these polymers;
a calcium ion (Ca2+);
at least one anion selected from the group consisting of a phosphate ion (PO43-), a carbonate ion (CO32-), and a mixture thereof; and
a contrast agent;
wherein the calcium ion and the phosphate ion form amorphous fine agglomerates, and the calcium ion and the carbonate ion form amorphous fine agglomerates, and
the hybrid particle is in the form of an aqueous dispersion in an aqueous medium, and has an average particle diameter within a range of 10 nm to 1000 nm, as measured by dynamic light-scattering of the dispersion, and
wherein the contrast agent is adhered onto a surface of the amorphous fine agglomerates or is wholly encapsulated by the amorphous fine agglomerates and is a metal selected from the group consisting of gadolinium (Gd), europium (Eu), manganese (Mn), iron (Fe) and copper (Cu), and is in the form of a metal chelate with an aminocarboxylic acid or phosphoric acid system polydentate ligand.
[claim2]
2. The hybrid particle of claim 1, wherein poly(hph) is derived from polyethylene glycol, and poly(carbo) is derived from a polymer selected from the group consisting of poly(aspartic acid), poly(glutamic acid), poly(methacrylic acid), poly(acrylic acid) and poly(malic acid).
[claim3]
3. The hybrid particle of claim 1, wherein the block copolymer is selected from the group consisting of the following formulae (II-a), (II-b), (III-a), (III-b) and (IV):

wherein in the above formulae, each symbol is independently selected,
A represents hydrogen or a substituted or unsubstituted alkyl having up to 12 carbon atoms,
L represents a direct bond or a divalent linker,
T represents hydrogen, hydroxyl or -- ZR in which Z represents a single bond, CO, O or NH, and R represents hydrogen or methyl group,
m is an integer of 4-2,500,
n is an integer of 5-10,000,
x+y is an integer of 5-1,000, and
z is an integer of 5-1,000,
wherein up to 50% of the carboxylate ion group present can either have a counter ion derived from an alkali metal or from a carboxy ester residue.
[claim4]
4. The hybrid particle of claim 3, wherein L represents a linker and is selected from the group consisting of O, NH, CO and X(CH2)pY, where X represents OCO, OCONH, NHCO, NHCOO, NHCONH, CONH or COO, Y represents NH or CO, and p is an integer of 1-6.
[claim5]
5. The hybrid particle of claim 1, wherein the aminocarboxylic acid or phosphoric acid system polydentate ligand is selected from the group consisting of ethylenediaminetetraacetic acid, diethylenetriaminepentaacetic acid, triethylenetetraminehexaacetic acid, ethylene glycol tetraminetetraacetic acid, tetraazacyclododecanetetraacetic acid, tetraazacyclododecanetriacetic acid and tetraazacyclododecanetetraphosphoric acid.
[claim6]
6. The hybrid particle of claim 1, wherein the block copolymer is selected from the group consisting of the following formulae (II-a), (II-b), (III-a), (III-b) and (IV):
wherein in the above formulae,
each symbol is independently selected,
A represents hydrogen or a substituted or unsubstituted alkyl having up to 12 carbon atoms,
L represents a direct bond or a divalent linker,
T represents hydrogen, hydroxyl or -- ZR in which Z represents a single bond, CO, O or NH, and R represents a hydrogen or methyl group,
m is an integer of 4-2,500,
n is an integer of 5-10,000,
x+y is an integer of 5-1,000, and
z is an integer of 5-1,000,
wherein up to 50% of the carboxylate ion group present can either have a counter ion derived from an alkali metal or from a carboxy ester residue;
and the contrast agent is a metal selected from the group consisting of gadolinium (Gd), europium (Eu), manganese (Mn), iron (Fe) and copper (Cu), the metal being in the form of a metal chelate with polydentate ligand of aminocarboxylic acid or phosphoric acid system, the aminocarboxylic acid or phosphoric acid system polydentate ligand being selected from the group consisting of ethylenediaminetetraacetic acid, diethylenetriaminepentaacetic acid, triethylenetetraminehexaacetic acid, ethylene glycol tetraminetetraacetic acid, tetraazacyclodecanetetraacetic acid, tetraazacyclododecanetriacetic acid, and tetraazacyclododecanetetraphosphoric acid.
[claim7]
7. The hybrid particle of claim 6, wherein L represents a linker and is selected from the group consisting of O, NH, CO and X(CH2)pY, where X represents OCO, OCONH, NHCO, NHCOO, NHCONH, CONH or COO, Y represents NH or CO, and p is an integer of 1-6.
[claim8]
8. The hybrid particle of claim 1, wherein average particle diameter in an aqueous dispersion of the particles is 50-600 nm as measured by dynamic light scattering method.
  • 発明者/出願人(英語)
  • KATAOKA KAZUNORI
  • KUMAGAI MICHIAKI
  • AIKAWA KEISUKE
  • JAPAN SCIENCE AND TECHNOLOGY AGENCY
国際特許分類(IPC)
米国特許分類/主・副
  • 424/9.1
  • 428/216
  • 428/221
  • 428/407
参考情報 (研究プロジェクト等) CREST Creation of Bio-Devices and Bio-Systems with Chemical and Biological Molecules for Medical Use AREA
ライセンスをご希望の方、特許の内容に興味を持たれた方は、問合せボタンを押してください。

PAGE TOP

close
close
close
close
close
close